Millions Pumped Into Stent Device

Biotechnology funding organization Cape Biotech has committed R6.7 million to DISA Vascular, a Cape-based medical device company that develops innovative vascular devices for the treatment of heart and peripheral vascular disease. The allocated funding will be used to develop their drug-eluting stent technology by taking the recently developed Stellium stent through human safety and efficacy trials.

Cape Business News (http://www.cbn.co.za/dailynews/February2005//article532.htm)